Blood product imports in South Sudan: data, top suppliers and prices
South Sudan imported $9.8 million of blood product in 2024 (45 tonnes). That is 367% more than in 2023. Over 2017-2024 the trade grew strongly, by about 47% a year on average.
Public statistics, latest complete year (2024). Values in US dollars. Page updated .
Imports by year, 2017-2024
Hover or tap a year for detail.
Year by year
| Year | Value | Quantity |
|---|---|---|
| 2024 | $9.8M | 45 t |
| 2023 | $2.1M | 10 t |
| 2022 | $2.9M | 100 t |
| 2021 | $9.4M | 286 t |
| 2020 | $5.0M | 366 t |
| 2019 | $3.6M | 308 t |
| 2018 | $3.4M | 273 t |
| 2017 | $672K | 20 t |
Where South Sudan imports blood product from
Most of the value came from South Korea (44%), Belgium (32%), India (16%). Among the main suppliers, Netherlands grew fastest, more than tenfold on the year before.
Product types under HS 3002
| 3002.20 | Human vaccines | 94% |
| 3002.11 | Malaria diagnostic test kits | 4.4% |
| 3002.15 | Immunological products (packaged) | 0.8% |
| 3002.12 | Antisera and blood fractions | 0.4% |
| 3002.30 | Veterinary vaccines | 0.3% |
| 3002.90 | Toxins and microorganism cultures | 0.2% |
Codes and full descriptions: HS heading 3002.
Average import price per kg
The average declared value was about $218.31 per kg, 71% below the world average of $759.25, which often means bulk or lower-grade product.
Declared value divided by weight, all 2024 shipments. Prices per shipment and per company are in EximDataX.
Who is behind these numbers in South Sudan?
The shipment records behind South Sudan blood product imports (HS 3002): companies, dates, quantities and declared values.
Shipment records are in the platform
Tell us what you trade and we will show you the latest records on a live call.
Mirror data: built from the shipment records of the countries that trade with it.
Source: CEPII BACI (reconciled UN Comtrade data), HS 2017 edition, release 202601, Etalab Open Licence 2.0. Annual values in US dollars at the customs border; quantities in tonnes where reported. HS 3002: Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc.
Common questions
What is the value of blood product imported by South Sudan?
South Sudan imported blood product worth $9.8 million in 2024, the latest year with complete public data, about 45 tonnes. That ranks it 153rd of 221 countries worldwide. The value was up 367% on 2023.
Which countries supply blood product to South Sudan?
South Korea was the largest supplier with 44% of the value ($4.3 million), followed by Belgium (32%) and India (16%). The top three together account for 91%, out of 14 supplier countries in total. India grew fastest among the top ten, up 181% on the year.
What is the average import price of blood product per kg?
The average declared import value was about $218.31 per kg in 2024, 71% below the world average of $759.25 per kg. Because it averages all grades and sizes, treat the figure as a market benchmark, not a price offer.
How have imports of blood product to South Sudan changed since 2017?
Imports went from $672 thousand in 2017 to $9.8 million in 2024. 2024 was the highest year in the period. Over 8 years the average was $4.6 million a year.
What is the HS code for blood product?
The HS code for blood product is heading 3002. In South Sudan the largest six-digit codes were 3002.20 (94% of the value) and 3002.11 (4%).
How can I find the companies behind this trade?
The totals here are public statistics; EximDataX adds the company names by reading partner countries' customs records for South Sudan. Tell us your product to see it live.
Same product, other countries
See what your buyers are buying.Then decide.
Everything we show you comes from official customs filings — records, not claims. 30 minutes. Your shipment. Your HS code. Real platform. If you don’t see something new about your market by the end of the call, we walk away. No follow-ups.